In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kyowa Kirin Co., Ltd.

https://www.kyowakirin.com/

Latest From Kyowa Kirin Co., Ltd.

Japan’s CEA Scheme: How It Works And Impact So Far

Japan has announced the latest evaluation results under its cost effectiveness assessment scheme. But how does it work and how much have prices been revised so far under the four-year-old program following discussions between pharma firms and authorities?

Japan Health Technology Assessment

MSD & Kyowa Question NICE’s Processes After English Funding Rejected For Rare Disease Drugs

MSD and Kyowa Kirin have separately criticized England’s HTA body, NICE, for assessing their respective rare disease medicines Welireg and Crysvita using its standard appraisal pathway. Both medicines were provisionally rejected for reimbursement.

Europe United Kingdom

Antiretroviral Pregnancy Registry Lights Way For Pregnancy Postmarketing Studies

The 30+ year-old program, which monitors prenatal exposure to 164 drugs, should be the template for other efforts, US FDA officials say, because disease-based pregnancy registries ‘have a better track record.’

Post Market Regulation & Studies Women's Health

Endo Launches First US Mitigare Generic Following Micro Labs Lawsuit

Endo’s Par has moved on the first FDA-approved generic version of Hikma’s Mitigare prevention of gout flares – weeks after another ANDA sponsor, Micro Labs, sought to clear its own path to market via a lawsuit.

Generic Drugs Launches
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Nutraceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Archimedes Pharma Ltd.
    • Centus Biotherapeutics Ltd.
    • Daiichi Fine Chemical Co., Ltd.
    • Fujifilm Kyowa Kirin Biologics Co., Ltd.
    • Kirin Pharma Company, Limited
    • Kyowa Kirin Asia Pacific Pte. Ltd.
    • Kyowa Kirin Australia Pty Ltd
    • Kyowa Kirin International PLC
    • Kyowa Pharma Chemical Co., Ltd.
    • ProStrakan Group plc
    • Kyowa Kirin
    • Kyowa Kirin Frontier Co., Ltd.
    • Kyowa Hakko Kirin (Singapore) Pte. Ltd.
    • Kyowa Hakko Kirin Co., Ltd.
UsernamePublicRestriction

Register